Also from this source

You just read:

Clinical Trial Utilizing BioAtla's Conditionally Active Biologics In CAR-T Candidates For Solid Tumors To Be Initiated In China

News provided by

BioAtla, LLC

Jan 08, 2018, 09:59 EST